Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lesley Arnold, MD
Study Principal Investigator
Principal Investigator - Michael Gendreau, MD
Consulting Chief Medical Officer
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site #37
Covina, California, United States
- Site #15
Oceanside, California, United States
- Site #31
San Bernardino, California, United States
- Site #38
Thousand Oaks, California, United States
- Site #36
Tujunga, California, United States
- Site #35
Whittier, California, United States
- Site #13
Orlando, Florida, United States
- Site #33
St. Petersburg, Florida, United States
- Site #25
Atlanta, Georgia, United States
- Site #21
Covington, Louisiana, United States
- Site #20
New Orleans, Louisiana, United States
- Site #22
Prairieville, Louisiana, United States
- Site #39
Chestnut Hill, Massachusetts, United States
- Site #24
Ocean Springs, Mississippi, United States
- Site #34
Brooklyn, New York, United States
- Site #32
Scarsdale, New York, United States
- Site #12
Williamsville, New York, United States
- Site #27
Fargo, North Dakota, United States
- Site #14
Cincinnati, Ohio, United States
- Site #28
Dayton, Ohio, United States
- Site #23
Tulsa, Oklahoma, United States
- Site #16
Allentown, Pennsylvania, United States
- Site #29
Austin, Texas, United States
- Site #26
McKinney, Texas, United States
- Site #30
Pflugerville, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Feb 2022
- Primary completion
- 15 May 2023
- Completion
- 15 May 2023
- Last update posted
- 15 Jun 2023
- Registered enrollment
- 275
- Registry id
- NCT05243511
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.